ferrous aspartoglycinate

Small moleculeexperimental

Clinical trial activity

1 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Apr 1, 2014 (NCT02128971)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • IronSupplementation

    Iron supplementation

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ferrous aspartoglycinate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02128971Phase 2Apr 1, 2014Albion, Sprim Consulting, University of Indonesia
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AlbionFor profit1112014
Sprim ConsultingFor profit1012014
University of IndonesiaAcademic/Hospital1012014
3 organizations
Page 1 / 1